Excess systemic circulation of pro-inflammatory cytokines including IL-8, IL-12p70, and TNF-α and a reduction in anti-inflammatory cytokines such as IL-10, could promote non-resolving inflammation in TB-DM patients with unfavorable effects on TB disease progression and anti-TB treatment outcomes [13]. This evidence concerns the gene TNF and diabetes mellitus.